Trading a NGNE straddle lets you take a pure volatility position on Neurogene Inc without committing to a direction. Neurogene Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate NGNE straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on NGNE profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Neurogene Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the NGNE straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the NGNE straddle is the cleanest expression of that view. Our scanner prices every NGNE straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a NGNE straddle into a catalyst or short a NGNE straddle to harvest decay, the options straddle setups that matter are all in one place.
